
PCSK9 inhibitors are among the most significant tools targeting high cholesterol to arrive since the first statins were approved by the FDA.

PCSK9 inhibitors are among the most significant tools targeting high cholesterol to arrive since the first statins were approved by the FDA.

Long-term care pharmacies have seen significant growth among select specialty categories.

Published: April 12th 2016 | Updated:

Published: October 12th 2016 | Updated: